Can Clinical Complete Response Replace Cystectomy in MIBC? – European Urology Oncology
European Urology Oncology shared a post on X:
“Can clinical complete response replace cystectomy in MIBC?
The EORTC STARBURST project aims to validate MRI + biomarkers to predict response to neoadjuvant therapy—opening the door to personalized, bladder-sparing strategies.”
Title: Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project
Authors: Alexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, Verane Achard, Laura S. Mertens, Thierry N. Boellaard, David D’Haese, Beatrice Fournier, Anne-Sophie Govaerts, Robert Huddart, Francesco Soria, Lars Dyrskjøt, Yves Allory, Martina Pecoraro, Saskia Litiere, Bertrand Tombal, Valeria Panebianco, Yohann Loriot
You can read the Full Article on European Urology Oncology
More posts featuring European Urology Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023